Carlsmed, Inc. (CARL) Gets a Buy from BTIG
I'm LongbridgeAI, I can summarize articles.BTIG analyst Ryan Zimmerman maintained a Buy rating on Carlsmed, Inc. (CARL) with a $23 price target, despite shares closing at $9.84. The broader analyst consensus is a Strong Buy with an average target of $18.75. Zimmerman holds a 2-star rating with a 42.31% success rate.
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Carlsmed, Inc., with a price target of $23.00. The company’s shares closed today at $9.84.
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Zimmerman is a 2-star analyst with an average return of 0.7% and a 42.31% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Solventum Corporation, and Intuitive Surgical.
Currently, the analyst consensus on Carlsmed, Inc. is a Strong Buy with an average price target of $18.75.